Results
57
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
57 companies
Avant Brands
Market Cap: CA$11.2m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$1.07
7D
-7.0%
1Y
-60.4%
Crescita Therapeutics
Market Cap: CA$10.1m
A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.
CTX
CA$0.53
7D
-5.4%
1Y
26.2%
Quest PharmaTech
Market Cap: CA$9.3m
A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.
QPT
CA$0.055
7D
83.3%
1Y
57.1%
Australis Capital
Market Cap: CA$8.7m
Operates as a cannabis company.
AUSA
CA$0.025
7D
0%
1Y
-82.8%
Medicure
Market Cap: CA$7.6m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$0.73
7D
-7.6%
1Y
-32.4%
Cytophage Technologies
Market Cap: CA$7.3m
A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.
CYTO
CA$0.14
7D
0%
1Y
-71.0%
Herbal Dispatch
Market Cap: CA$5.3m
Owns and operates cannabis e-commerce platforms in Canada and the United States.
HERB
CA$0.065
7D
8.3%
1Y
30.0%
Delivra Health Brands
Market Cap: CA$5.3m
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
DHB
CA$0.17
7D
-10.5%
1Y
-51.4%
FinCanna Capital
Market Cap: CA$5.0m
Does not have significant operations.
CALI.X
CA$0.005
7D
0%
1Y
n/a
Ayurcann Holdings
Market Cap: CA$4.9m
Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.
AYUR
CA$0.025
7D
-16.7%
1Y
-37.5%
XORTX Therapeutics
Market Cap: CA$4.5m
A late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection.
XRTX
CA$1.20
7D
-6.3%
1Y
-74.0%
Awakn Life Sciences
Market Cap: CA$4.0m
A biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe.
AWKN
CA$0.095
7D
0%
1Y
-26.9%
1933 Industries
Market Cap: CA$2.5m
Engages in the cultivation, extraction, and production of cannabis products in the United States.
TGIF
CA$0.005
7D
0%
1Y
-75.0%
Biocure Technology
Market Cap: CA$2.4m
Together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab.
CURE.X
CA$0.025
7D
0%
1Y
n/a
Captor Capital
Market Cap: CA$2.1m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.59
7D
-4.8%
1Y
-28.5%
West Island Brands
Market Cap: CA$2.0m
Engages in the medical marijuana business.
WIB
CA$0.13
7D
0%
1Y
4.0%
Adastra Holdings
Market Cap: CA$1.9m
Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.
XTRX
CA$0.34
7D
0%
1Y
-86.0%
RAMM Pharma
Market Cap: CA$1.8m
Through its subsidiaries, operates pharmaceutical and medical product business in Uruguay, Italy, and Poland.
RAMM
CA$0.015
7D
0%
1Y
-75.0%
Street Capital
Market Cap: CA$1.4m
Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.
STRC.X
CA$0.005
7D
0%
1Y
0%
Lowell Farms
Market Cap: CA$544.5k
Engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California.
LOWL
CA$0.03
7D
0%
1Y
-78.6%
Many Bright Ideas Technologies
Market Cap: CA$345.2k
Does not have significant operations.
MBI.H
CA$0.02
7D
0%
1Y
-78.9%